Noémie Heymann

Noémie Heymann has a diverse work experience in the field of clinical research and scientific advisory roles. Noémie served as a Clinical Supply Lead at Nanobiotix since August 2021. Prior to that, they worked as a Manager Clinical Supply at DBV Technologies from December 2018 to July 2021. Noémie also gained experience as a Clinical Research Associate at PRA Health Sciences from January 2016 to November 2018. Noémie held positions at URC HEGP, APHP, Eli Lilly and Company, School of Engineering at Bar Ilan University, and EEIF in various research and advisory roles.

Noémie Heymann completed a Master 1 in Biologie Cellulaire et Moléculaire at Université Paris 6 Pierre et Marie Curie from 2009 to 2012, followed by a Master 2 in Développement des produits de santé at Paris 7 Denis Diderot from 2012 to 2013. In 2014, they obtained a Certificat d'Attaché de Recherche Clinique in Reglementation et monitoring from Institut Léonard de Vinci.